Safety and Feasibility of the ELIOS System in POAG Patients | MicrobiomeTrials← Back to trialsNCT05999006
Safety and Feasibility of the ELIOS System in POAG Patients
CompletedNAINTERVENTIONAL
Trial Details
Start: 2023-10-18Est. Completion: 2026-04-28
Enrollment target: 22 participants Locations- Elios Vision Clinical Site, Glendale, Arizona, United States
- Elios Vision Clinical Site, Rock Island, Illinois, United States
- Elios Vision Clinical Site, St Louis, Missouri, United States
- Elios Vision Clinical Site, Oklahoma City, Oklahoma, United States
- Elios Vision Clinical Site, El Paso, Texas, United States
- Elios Vision Clinical Site, Kenosha, Wisconsin, United States
Other microbiome trials you might be interested in
Glaucoma, Primary Open Angle
Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult s…
Glendale, United StatesCompleted Jul 29, 2025
POAGMIGS
Primary open-angle glaucoma (POAG) is a chronic eye disease in which the only validated treatment is to lower intraocula…
Amiens, FranceEst. completion Jun 2026